Securities Analyst Recommendations: EQT Corporation (EQT), Novanta Inc. (NOVT)

EQT Corporation (NYSE:EQT) tinted gains of +1.12% (+0.22 points) to US$19.86. The volume of 3.76 Million shares climbed down over an trading activity of 5.02 Million shares. EPS ratio determined by looking at last 12 month figures is -10.01. Over the same time span, the stock marked US$31.24 as its best level and the lowest price reached was US$16.29. The corporation has a market cap of US$5.2 Billion.

EQT Corporation (NYSE:EQT)’s earnings per share has been growing at a -47.9 percent rate over the past 5 year when average revenue increase was noted as 19.6 percent. The return on equity ratio or ROE stands at -19.8 percent while most common profitability ratio return on investment (ROI) was -12.6 percent. The company’s institutional ownership is monitored at 0 percent. The company’s net profit margin has achieved the current level of -49.2 percent and possesses 58.4 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 5 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 6 think it is Hold. Recently, analysts have updated the overall rating to 2.16. 7 analysts recommended Overweight these shares while 1 recommended Underweight, according to FactSet data.

Novanta Inc. (NASDAQ:NOVT) is worth US$2.98 Billion and has recently risen 1.12% to US$84.88. The latest exchange of 0.12 Million shares is below its average trading activity of 159.7 Million shares. The day began at US$83.94 but the price moved to US$83.42 at one point during the trading and finally capitulating to a session high of US$85.39. The stock tapped a 52-week high of US$84.86 while the mean 12-month price target for the shares is US$81.

Currently, the stock carries a price to earnings ratio of 61.29, a price to book ratio of 8.05, and a price to sales ratio of 4.85. For the past 5 years, the company’s revenue has grown 14.2%, while the company’s earnings per share has grown 36.8%. With an institutional ownership near 88%, it carries an earnings per share ratio of 1.39.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 1 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.